| Literature DB >> 27410465 |
Nicolas Maindron1, Martin Ipuy1, Claire Bernhard1, Damien Lhenry1, Mathieu Moreau1, Sabin Carme1, Alexandra Oudot2, Bertrand Collin1,2, Jean-Marc Vrigneaud2, Peggy Provent3, François Brunotte2, Franck Denat4, Christine Goze5.
Abstract
A new generation of monomolecular imaging probes (MOMIP) based on a distyryl-BODIPY (BODIPY=boron-dipyrromethene) coupled with three DOTA macrocycles has been prepared (DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). The MOMIP presents good fluorescence properties and is very stable in serum. The bimodal probe was conjugated to trastuzumab, and an optical in vivo study showed high accumulation of the imaging agent at the tumor site. (111) In radiometallation of the bioconjugate was performed in high radiochemical yield, highlighting the potential of this new BODIPY-chelators derivative as a bimodal imaging probe.Entities:
Keywords: BODIPY; DOTA; MOMIP; bimodal probes; optical imaging
Year: 2016 PMID: 27410465 DOI: 10.1002/chem.201602886
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236